文献速递脊柱脊髓外科

经椎间孔入路经皮内镜下病灶清除同种异体骨植骨联合经皮椎弓根螺钉内固定治疗单节段胸椎结核:中位随访36个月的多中心研究

Treatment of Single-Level Thoracic Tuberculosis by Percutaneous Endoscopic Débridement and Allograft via the Transforaminal Approach Combined with Percutaneous Pedicle Screw Fixation: A Multicenter Study with a Median Follow-Up of 36 Months.
PubMed 文献 · World Neurosurg · 2018-11-19

这项多中心回顾性分析纳入75例单节段胸椎结核患者,接受经椎间孔入路经皮内镜下病灶清除同种异体骨植骨联合经皮椎弓根螺钉内固定,随访超过36个月。随访36-48个月(平均41.1±2.2个月),无复发病例,96%患者获得I或II级椎间融合,所有患者神经功能恢复至美国脊髓损伤协会E级,视觉模拟评分和36项简表健康调查评分在随访各时间点显著改善,并发症率为9.0%。作者认为该技术安全、有效、可行且微创。

要点

  • 75例单节段胸椎结核患者接受经椎间孔入路经皮内镜下病灶清除植骨联合经皮椎弓根螺钉固定。
  • 随访36-48个月,无复发病例,96%患者获得I或II级椎间融合。
  • 所有患者神经功能恢复至美国脊髓损伤协会E级,并发症率为9.0%。

核心结论

  • 中位随访临床经验表明,经椎间孔入路经皮内镜下病灶清除同种异体骨植骨联合经皮椎弓根螺钉内固定治疗单节段胸椎结核安全、有效、可行且微创。

研究设计与样本

  • 多中心回顾性分析,纳入2012年1月至2014年12月间75例接受经椎间孔入路经皮内镜下病灶清除同种异体骨植骨联合经皮椎弓根螺钉内固定且随访超过36个月的单节段胸椎结核患者。

主要发现

  • 随访36-48个月(平均41.1±2.2个月),术中出血量平均30.5±7.9 mL,卧床时间平均1.5±0.3天。
  • 全部75例患者均未观察到复发;除3例患者外,96%的患者椎间植骨获得I或II级融合。
  • 节段性Cobb角术前为13.5°±4.1°,术后即刻为10.5°±3.7°,随访36个月时为11.7°±3.9°。
  • 所有患者神经功能完全恢复至美国脊髓损伤协会E级,包括术前15例美国脊髓损伤协会D级脊髓损伤患者。
  • 视觉模拟评分和36项简表健康调查评分在随访1、3、12和36个月时显著改善;随访期内无内固定相关并发症,并发症率为9.0%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine effects of percutaneous endoscopic débridement and allograft via the transforaminal approach combined with percutaneous pedicle screw fixation as treatment for single-level thoracic tuberculosis. METHODS: This multicenter retrospective analysis included 75 patients with single-level thoracic tuberculosis who underwent percutaneous endoscopic débridement and allograft via the transforaminal approach combined with percutaneous pedicle screw fixation and were followed for >36 months between January 2012 and December 2014. RESULTS: Follow-up was 36-48 months (average 41.1 ± 2.2 months). Intraoperative blood loss was low (average 30.5 ± 7.9 mL), and bed rest time was short (average 1.5 ± 0.3 days). No recurrence was observed in all 75 patients. Except for 3 patients, almost all patients (96%) achieved grade I or II fusion in interbody bone grafting. Segmental Cobb angle was 13.5° ± 4.1° before surgery, 10.5° ± 3.7° immediately after surgery, and 11.7° ± 3.9° at 36 months of follow-up. All patients achieved complete recovery of neurologic function (American Spinal Injury Association grade E), including 15 patients with spinal cord injury (American Spinal Injury Association grade D) before surgery. The visual analog scale and 36-Item Short-Form Health Survey scores significantly improved at 1, 3, 12, and 36 months of follow-up. No complications related to internal fixation occurred within the follow-up period; complication rate was 9.0%. CONCLUSIONS: Median follow-up clinical experience with percutaneous endoscopic débridement and allograft via the transforaminal approach combined with percutaneous pedicle screw fixation indicates that the technique is safe, effective, feasible, and minimally invasive.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Yang JS, Chu L, Deng R, et al. Treatment of Single-Level Thoracic Tuberculosis by Percutaneous Endoscopic Débridement and Allograft via the Transforaminal Approach Combined with Percutaneous Pedicle Screw Fixation: A Multicenter Study with a Median Follow-Up of 36 Months. World Neurosurg. 2018. PMID: 30465947. doi:10.1016/j.wneu.2018.11.087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。